Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy.
Terranova CJ, Tang M, Maitituoheti M, Raman AT, Ghosh AK, Schulz J, Amin SB, Orouji E, Tomczak K, Sarkar S, Oba J, Creasy C, Wu CJ, Khan S, Lazcano R, Wani K, Singh A, Barrodia P, Zhao D, Chen K, Haydu LE, Wang WL, Lazar AJ, Woodman SE, Bernatchez C, Rai K.
Terranova CJ, et al. Among authors: khan s.
Cell Rep. 2021 Jul 20;36(3):109410. doi: 10.1016/j.celrep.2021.109410.
Cell Rep. 2021.
PMID: 34289358
Free PMC article.